drugset / Trial / NCT00432679
A Study Of BRL49653C For The Treatment Of Type 2 Diabetes (Combination Therapy With Sulfonyl Urea) -With Placebo Study
RandomizedParallel-groupDouble-blindTreatment
Summary
This study was designed to compare the efficacy and safety of BRL49653C versus placebo with concomitant use of sulfonyl urea (SU).
Timeline
- Start
- 2006-05-24
- Primary completion
- 2007-03-28
- Completion
- 2007-03-28
Publications
- Background This study has not been published in the scientific literature.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rosiglitazone | Small molecule | — | — |